Milestone Pharmaceuticals (MIST) filed a registration statement late Wednesday for the sale of up to $300 million of securities from time to time in one or more offerings.

The securities cover common and preferred shares, debt securities, and warrants, the filing showed.

Net proceeds will be used for working capital and general corporate purposes, it said.